Abiopharma

🔍 Taylor Brenton (Executive)

Company: Sight Sciences, Inc. (SGHT)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Acquired 25,840 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: A | equity_swap_involved: false | shares_owned_after: 185,840.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing September 30, 2025 and continuing through June 30, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $100,000 of shares of Common Stock as determined by the closing price on the grant date, September 2, 2025. The RSUs have no expiration date.